Assyro AI
Orange Book product · Brand (NDA)

Aminophylline In Sodium Chloride 0.45% In Plastic Container

Aminophylline

Brand (NDA)NDA 018924Discontinued Hospira
Approved
Dec 12, 1984
Application
Brand (NDA)
TE code
Not listed
Listed patents
0
Aminophylline In Sodium Chloride 0.45% In Plastic Container (Aminophylline) is Hospira's brand-name drug, approved by the FDA under NDA 018924 in 1984. Its marketing status is listed as discontinued; a discontinued listing is not, by itself, a finding that the drug was withdrawn for safety or effectiveness. 48 approved generics share this drug's active ingredient.

Sourced from the FDA Orange Book

Approval, patents, exclusivity

Key dates

Key dates

  1. Approval

    FDA approval date of this drug product.

    Dec 12, 1984

    42 yr 2 mo ago

  2. Today

FDA product record

Pharmaceutical detail

Pharmaceutical detail

Active ingredient

AMINOPHYLLINE

Strength

100MG/100ML

Dosage form

INJECTABLE

Route

INJECTION

TE code

Not listed

Application

NDA 018924

Product number

001

Marketing status

Discontinued

Reference listed drug (RLD)

No

Reference standard (RS)

No

Same application

Other strengths in NDA 018924

Brand + generics

Active-ingredient family

Orange Book patent file

Listed patents

Listed patents

No patents are listed against this product in the Orange Book. Listed patents reflect those the NDA holder submits under 21 U.S.C. 355 and are not exhaustive.

Aminophylline In Sodium Chloride 0.45% In Plastic Container — frequently asked questions

Approval, therapeutic equivalence, patents, and exclusivity for this product, from the FDA Orange Book.

Built directly from the FDA Orange Book data file. This product page links back to the Aminophylline active-ingredient family, which is the canonical reference for generics, patents, and exclusivity across all strengths.

Related FDA reference tools

Agent CTA Background

Your Next Submission Could Take 6+ Fewer Weeks and Cost $250K Less.